Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Sandström

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Alimentary Pharmacology & Therapeutics|May 27, 2026
Socioeconomic Inequalities in Receipt of Curative-Intent Treatment and Survival After Surveillance-Detected Hepatocellular Carcinoma: A Nationwide Cohort StudyHannes Hagström, Jeffrey V Lazarus, Malin Sternby Eilard, et al.
Worldviews on Evidence-Based Nursing|May 24, 2022
Patient preferences and experiences of participation in surgical cancer careJenny Drott, Victoria Fomichov, Maria Nordén, et al.
The Journal of Pathology|December 28, 2019
Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinomaEric Morin, Cecilia Lindskog, Martin Johansson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 12, 2022
Complications and chemotherapy have little impact on postoperative quality of life after pancreaticoduodenectomy - a cohort studyKarin Johansen, Anna Lindhoff Larsson, Thomas Gasslander, et al.
Trials|May 5, 2026
Postoperative drainage after pancreatoduodenectomy: a randomized controlled trial among patients with intermediate and low risks for pancreatic fistula-DRAIN1Sebastian Wallon, Caroline Williamsson, Victor Karlsson, et al.
BMC Cancer|June 8, 2014
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinomaJacob Farnebo, Per Grybäck, Ulrika Harmenberg, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinomaChrister Svedman, Per Sandström, Pavel Pisa, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 22, 2016
Association of ecological factors with Rift Valley fever occurrence and mapping of risk zones in KenyaGladys Mosomtai, Magnus Evander, Per Sandström, et al.
The Journal of Surgical Research|October 4, 2011
Remote or conventional ischemic preconditioning--local liver metabolism in rats studied with microdialysisBergthor Björnsson, Anders Winbladh, Linda Bojmar, et al.
Oncotarget|February 27, 2016
MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumorPraneeth R Kuninty, Linda Bojmar, Vegard Tjomsland, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Alimentary Pharmacology & Therapeutics|May 27, 2026
Socioeconomic Inequalities in Receipt of Curative-Intent Treatment and Survival After Surveillance-Detected Hepatocellular Carcinoma: A Nationwide Cohort StudyHannes Hagström, Jeffrey V Lazarus, Malin Sternby Eilard, et al.
Worldviews on Evidence-Based Nursing|May 24, 2022
Patient preferences and experiences of participation in surgical cancer careJenny Drott, Victoria Fomichov, Maria Nordén, et al.
The Journal of Pathology|December 28, 2019
Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinomaEric Morin, Cecilia Lindskog, Martin Johansson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 12, 2022
Complications and chemotherapy have little impact on postoperative quality of life after pancreaticoduodenectomy - a cohort studyKarin Johansen, Anna Lindhoff Larsson, Thomas Gasslander, et al.
Trials|May 5, 2026
Postoperative drainage after pancreatoduodenectomy: a randomized controlled trial among patients with intermediate and low risks for pancreatic fistula-DRAIN1Sebastian Wallon, Caroline Williamsson, Victor Karlsson, et al.
BMC Cancer|June 8, 2014
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinomaJacob Farnebo, Per Grybäck, Ulrika Harmenberg, et al.
Acta Oncologica (Stockholm, Sweden)|September 20, 2006
A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinomaChrister Svedman, Per Sandström, Pavel Pisa, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 22, 2016
Association of ecological factors with Rift Valley fever occurrence and mapping of risk zones in KenyaGladys Mosomtai, Magnus Evander, Per Sandström, et al.
The Journal of Surgical Research|October 4, 2011
Remote or conventional ischemic preconditioning--local liver metabolism in rats studied with microdialysisBergthor Björnsson, Anders Winbladh, Linda Bojmar, et al.
Oncotarget|February 27, 2016
MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumorPraneeth R Kuninty, Linda Bojmar, Vegard Tjomsland, et al.
Pageof 14